Niren Shah, Pharm.D., MBA

VP of Program & Alliance Management and Chief of Staff

Brings over a decade of rare disease industry expertise to Taysha; with experience at Novartis, NPS Pharma, most recently focused on M&A and strategic in-licensing of multiple CNS gene therapy assets while in business development at PTC Therapeutics.

Copyright 2020- Taysha GTx